Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vertex Pharmaceuticals Incorporated
Age
12–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Estimated glomerular filtration rate (eGFR) greater than or equal to (≥) 30 milliliter per minute (mL/min)/1.73 m\^2
Willing and able to comply with scheduled visits and other study procedures
A pre-existing diagnosis of ADPKD as defined in the protocol
You may not be if
History of kidney disease other than ADPKD that in the opinion of the investigator would independently impact the natural history of ADPKD
History of solid organ or bone marrow transplantation or nephrectomy
Ongoing renal replacement therapy or planning to start renal replacement therapy less than or equal to (≤)12 months from the Genotyping Visit in Part A
Clareo Health | Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease
